Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis
InnoCare to move to phase 3 after achieving SLE endpoints
First precision therapy prostate cancer drug approved
FDA approves generalised myasthenia gravis drug
How automation protects food and beverage workers from the dangers of palletising
Revolutionary self-sensing electric artificial muscles